Physician profile
Katherine Nikopoulos
NPI 1912777293
$4,519.46
in general payments reported to CMS, 2019-2025
20 companies · $3,210 in 2025
The $3,210 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,310 · 2025: $3,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,510 · Travel and Lodging: $1,749 · Consulting Fee: $150 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,510.35 |
| Travel and Lodging | $1,749.27 |
| Consulting Fee | $150.00 |
| Education | $109.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,198.67 | 2024-2025 | Cardiomems |
| Astrazeneca Pharmaceuticals LP | $329.86 | 2024-2025 | Wainua, Lokelma, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.67 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $253.68 | 2024-2025 | Verquvo, Winrevair |
| United Therapeutics Corporation | $252.55 | 2024-2025 | Tyvaso |
| E.R. Squibb & Sons, L.L.C. | $238.52 | 2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $210.57 | 2024-2025 | Amvuttra, Onpattro |
| Actelion Pharmaceuticals US, INC. | $176.72 | 2024-2025 | Uptravi, Opsumit |
| Johnson & Johnson Health Care Systems INC. | $97.15 | 2024 | Opsumit, Uptravi |
| Philips North America LLC | $72.24 | 2024-2025 | Mcot, (Ck4) Mcot |
| Kiniksa Pharmaceuticals International, Plc | $70.31 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $58.54 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $53.10 | 2025 | |
| Kestra Medical Technology Services, INC. | $47.26 | 2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $38.27 | 2025 | Optimizer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $31.05 | 2024-2025 | |
| Heartflow, INC. | $22.85 | 2025 | |
| Scpharmaceuticals INC. | $20.90 | 2025 | |
| Analog Devices INC. | $17.13 | 2025 | Sensinel Cpm Wearable |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.42 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Nikopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.